Skip to main content
Top
Published in: Indian Journal of Gastroenterology 1/2011

01-02-2011 | Original Article

Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India

Authors: Mahesh Kumar Goenka, Shounak Majumder, Pradeepta Kumar Sethy, Madhurima Chakraborty

Published in: Indian Journal of Gastroenterology | Issue 1/2011

Login to get access

Abstract

Introduction

The past decade has witnessed a global rise in the prevalence of peptic ulcer disease which is unrelated to non-steroidal anti-inflammatory drugs (NSAIDs) or Helicobacter pylori infection. Although initially recognized in the West, this disease is being increasingly recognized in the Asian population. The higher risk of bleeding and ulcer recurrence in this subgroup of patients highlights the clinical importance of analyzing the changing trends of peptic ulcer disease in developing countries.

Aims

To assess the proportion of non-NSAID, non-H. pylori peptic ulcer disease in an Indian cohort of patients with peptic ulcer disease managed at a tertiary care center; and to compare the gastric and duodenal ulcer subgroups in these patients.

Methods

Patients diagnosed with peptic ulcer disease were screened for a history of NSAID use and those with a negative history were tested for H. pylori using a combination of rapid urease test (RUT) and 14C-urea breath test (UBT). Only those cases which tested negative for both the tests were considered ‘H. pylori-negative’. Serum gastrin was measured in all patients included in the study.

Results

Seventy-four gastric ulcer (GU) and 54 duodenal ulcer (DU) patients with no history of NSAID use were enrolled. Of these, 36 GU (45.9%) and 16 DU (29.6%) patients were H. pylori-negative. The proportion of non-NSAID non-H. pylori gastric ulcers was significantly higher than duodenal ulcers (p < 0.05). However, patients who tested negative for H. pylori did not differ significantly from those who tested positive with regard to age, gender, serum gastrin level, and presence of risk factors, like smoking and alcoholism.

Conclusion

The current study indicates existence of high proportion of non-NSAID, non-H. pylori peptic ulcer disease in Indian patients.
Literature
1.
go back to reference Arroyo MT, Forne M, de Argila CM, et al. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti inflammatory drug use is negligible in Southern Europe. Helicobacter. 2004;9:249–54.PubMedCrossRef Arroyo MT, Forne M, de Argila CM, et al. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti inflammatory drug use is negligible in Southern Europe. Helicobacter. 2004;9:249–54.PubMedCrossRef
2.
go back to reference Jyotheeswaran S, Shah AN, Jim HO, et al. Prevalence of Helicobacter pylori in peptic ulcer patients in Great Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol. 1998;93:574–8.PubMedCrossRef Jyotheeswaran S, Shah AN, Jim HO, et al. Prevalence of Helicobacter pylori in peptic ulcer patients in Great Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol. 1998;93:574–8.PubMedCrossRef
3.
4.
go back to reference Fujisawa T, Kumagai T, Akamatsu T, et al. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol. 1999;94:2094–9.PubMedCrossRef Fujisawa T, Kumagai T, Akamatsu T, et al. Changes in seroepidemiological pattern of Helicobacter pylori and hepatitis A virus over the last 20 years in Japan. Am J Gastroenterol. 1999;94:2094–9.PubMedCrossRef
5.
go back to reference Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–31.PubMedCrossRef Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–31.PubMedCrossRef
6.
go back to reference Yeomans ND, Naesdal J. Systematic review: ulcer definition in NSAID ulcer prevention trials. Aliment Pharmacol Ther. 2008;27:465–72.PubMedCrossRef Yeomans ND, Naesdal J. Systematic review: ulcer definition in NSAID ulcer prevention trials. Aliment Pharmacol Ther. 2008;27:465–72.PubMedCrossRef
7.
go back to reference Hegedus O, Rydén J, Rehnberg AS, et al. Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in-office analysis. Eur J Gastroenterol Hepatol. 2002;14:513–20.PubMedCrossRef Hegedus O, Rydén J, Rehnberg AS, et al. Validated accuracy of a novel urea breath test for rapid Helicobacter pylori detection and in-office analysis. Eur J Gastroenterol Hepatol. 2002;14:513–20.PubMedCrossRef
8.
go back to reference Borody TJ, George LL, Brandl S, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol. 1991;86:1154–7.PubMed Borody TJ, George LL, Brandl S, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol. 1991;86:1154–7.PubMed
9.
go back to reference Borody TJ, Brandl S, Andrews P, et al. Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol. 1992;87:1403–6.PubMed Borody TJ, Brandl S, Andrews P, et al. Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol. 1992;87:1403–6.PubMed
10.
go back to reference Xia HH, Phung N, Kalantar JS, et al. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000;173:515–9.PubMed Xia HH, Phung N, Kalantar JS, et al. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust. 2000;173:515–9.PubMed
11.
go back to reference Gisbert JP, Blanco M, Mateos JM, et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci. 1999;44:2295–302.PubMedCrossRef Gisbert JP, Blanco M, Mateos JM, et al. H. pylori-negative duodenal ulcer prevalence and causes in 774 patients. Dig Dis Sci. 1999;44:2295–302.PubMedCrossRef
12.
go back to reference Bytzer P, Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis—results from a randomized trial with 2-year follow-up. Am J Gastroenterol. 2001;96:1409–16.PubMed Bytzer P, Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis—results from a randomized trial with 2-year follow-up. Am J Gastroenterol. 2001;96:1409–16.PubMed
13.
go back to reference Oderda G, Mura S, Valori A, et al. Idiopathic peptic ulcers in children. J Pediatr Gastroenterol Nutr. 2009;48:268–70.PubMedCrossRef Oderda G, Mura S, Valori A, et al. Idiopathic peptic ulcers in children. J Pediatr Gastroenterol Nutr. 2009;48:268–70.PubMedCrossRef
14.
go back to reference Nishikawa K, Sugiyama T, Kato M, et al. Non-Helicobacter pylori, non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol. 2000;12:635–40.PubMedCrossRef Nishikawa K, Sugiyama T, Kato M, et al. Non-Helicobacter pylori, non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol. 2000;12:635–40.PubMedCrossRef
15.
go back to reference Chan HL, Wu JC, Chan FK, et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI Bleeding? A prospective study of 977 patients. Gastrointest Endosc. 2001;53:438–42.PubMedCrossRef Chan HL, Wu JC, Chan FK, et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI Bleeding? A prospective study of 977 patients. Gastrointest Endosc. 2001;53:438–42.PubMedCrossRef
16.
go back to reference Hung LC, Ching JY, Sung JJ, et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology. 2005;128:1845–50.PubMedCrossRef Hung LC, Ching JY, Sung JJ, et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study. Gastroenterology. 2005;128:1845–50.PubMedCrossRef
17.
go back to reference Ciociola AA, McSorley DJ, Turner K, et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol. 1999;94:1834–40.PubMedCrossRef Ciociola AA, McSorley DJ, Turner K, et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol. 1999;94:1834–40.PubMedCrossRef
18.
go back to reference Hobsley M, Tovey FI. Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection? World J Gastroenterol. 2001;7:149–51.PubMed Hobsley M, Tovey FI. Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection? World J Gastroenterol. 2001;7:149–51.PubMed
19.
go back to reference Tovey FI, Hobsley M. Is Helicobacter pylori the primary cause of duodenal ulceration? J Gastroenterol Hepatol. 1999;14:1053–6.PubMedCrossRef Tovey FI, Hobsley M. Is Helicobacter pylori the primary cause of duodenal ulceration? J Gastroenterol Hepatol. 1999;14:1053–6.PubMedCrossRef
20.
go back to reference Chow DK, Sung JJ. Non-NSAID non-H. pylori ulcer disease. Best Pract Res Clin Gastroenterol. 2009;23:3–9.PubMedCrossRef Chow DK, Sung JJ. Non-NSAID non-H. pylori ulcer disease. Best Pract Res Clin Gastroenterol. 2009;23:3–9.PubMedCrossRef
21.
go back to reference McColl KE. How I manage H. pylori-negative, NSAID/aspirin negative peptic ulcers. Am J Gastroenterol. 2009;104:190–3.PubMedCrossRef McColl KE. How I manage H. pylori-negative, NSAID/aspirin negative peptic ulcers. Am J Gastroenterol. 2009;104:190–3.PubMedCrossRef
22.
go back to reference Meucci G, Di Battista R, Abbiati C, et al. Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer. J Clin Gastroenterol. 2000;31:42–7.PubMedCrossRef Meucci G, Di Battista R, Abbiati C, et al. Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer. J Clin Gastroenterol. 2000;31:42–7.PubMedCrossRef
23.
go back to reference Higuchi K, Arakawa T, Fujiwara Y, et al. Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H. pylori infection in the general population? Am J Gastroenterol. 1999;94:3083–4.PubMedCrossRef Higuchi K, Arakawa T, Fujiwara Y, et al. Is Helicobacter pylori-negative duodenal ulcer masked by the high prevalence of H. pylori infection in the general population? Am J Gastroenterol. 1999;94:3083–4.PubMedCrossRef
24.
go back to reference Vu C, Ng YY. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore Hospital. Singapore Med J. 2000;41:478–81.PubMed Vu C, Ng YY. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore Hospital. Singapore Med J. 2000;41:478–81.PubMed
25.
go back to reference Yakoob J, Jafri W, Jafri N, et al. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. World J Gastroenetrol. 2005;11:3562–5. Yakoob J, Jafri W, Jafri N, et al. Prevalence of non-Helicobacter pylori duodenal ulcer in Karachi, Pakistan. World J Gastroenetrol. 2005;11:3562–5.
26.
go back to reference Mishra S, Singh V, Rao GR, et al. Prevalence of Helicobacter pylori in asymptomatic subjects—a nested PCR based study. Infect Genet Evol. 2008;8:815–9.PubMedCrossRef Mishra S, Singh V, Rao GR, et al. Prevalence of Helicobacter pylori in asymptomatic subjects—a nested PCR based study. Infect Genet Evol. 2008;8:815–9.PubMedCrossRef
27.
go back to reference Jain A, Buddhiraja S, Khurana B, et al. Risk factors for duodenal ulcer in north India. Trop Gastroenterol. 1999;20:36–9.PubMed Jain A, Buddhiraja S, Khurana B, et al. Risk factors for duodenal ulcer in north India. Trop Gastroenterol. 1999;20:36–9.PubMed
28.
go back to reference Singh V, Trikha B, Nain CK, et al. Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol. 2002;17:659–65.PubMedCrossRef Singh V, Trikha B, Nain CK, et al. Epidemiology of Helicobacter pylori and peptic ulcer in India. J Gastroenterol Hepatol. 2002;17:659–65.PubMedCrossRef
29.
go back to reference Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002;97:2950–61.PubMedCrossRef Quan C, Talley NJ. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs. Am J Gastroenterol. 2002;97:2950–61.PubMedCrossRef
30.
go back to reference Kemppainen H, Raiha I, Sourander L. Clinical presentation of peptic ulcer in the elderly. Gerontology. 1997;43:283–8.PubMedCrossRef Kemppainen H, Raiha I, Sourander L. Clinical presentation of peptic ulcer in the elderly. Gerontology. 1997;43:283–8.PubMedCrossRef
31.
go back to reference Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772–81.PubMedCrossRef Malfertheiner P, Megraud F, O’Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772–81.PubMedCrossRef
32.
go back to reference Wong GLH, Ching JYL, Chan Y, et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a 7-year prospective cohort study. Gastroenterology. 2008;134 Suppl 1:A75. Wong GLH, Ching JYL, Chan Y, et al. Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a 7-year prospective cohort study. Gastroenterology. 2008;134 Suppl 1:A75.
33.
go back to reference Goenka MK, Kochhar R, Ghosh P, et al. Changing pattern of peptic ulcer in India. An endoscopic study of 1188 ulcer patients. J Clin Gastroenterol. 1991;13:575–9.PubMedCrossRef Goenka MK, Kochhar R, Ghosh P, et al. Changing pattern of peptic ulcer in India. An endoscopic study of 1188 ulcer patients. J Clin Gastroenterol. 1991;13:575–9.PubMedCrossRef
Metadata
Title
Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India
Authors
Mahesh Kumar Goenka
Shounak Majumder
Pradeepta Kumar Sethy
Madhurima Chakraborty
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 1/2011
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0085-9

Other articles of this Issue 1/2011

Indian Journal of Gastroenterology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.